rs115898419
Positions:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_024867.4(SPEF2):c.2840-13G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0224 in 1,612,932 control chromosomes in the GnomAD database, including 714 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.019 ( 64 hom., cov: 34)
Exomes 𝑓: 0.023 ( 650 hom. )
Consequence
SPEF2
NM_024867.4 intron
NM_024867.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.362
Genes affected
SPEF2 (HGNC:26293): (sperm flagellar 2) Involved in sperm axoneme assembly. Located in sperm flagellum. Implicated in spermatogenic failure 43. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.26).
BP6
Variant 5-35712799-G-A is Benign according to our data. Variant chr5-35712799-G-A is described in ClinVar as [Benign]. Clinvar id is 403480.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0818 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPEF2 | NM_024867.4 | c.2840-13G>A | intron_variant | ENST00000356031.8 | NP_079143.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPEF2 | ENST00000356031.8 | c.2840-13G>A | intron_variant | 1 | NM_024867.4 | ENSP00000348314.3 | ||||
SPEF2 | ENST00000637569.1 | c.2840-13G>A | intron_variant | 5 | ENSP00000490886.1 | |||||
SPEF2 | ENST00000440995.6 | c.2825-13G>A | intron_variant | 5 | ENSP00000412125.2 | |||||
ENSG00000248969 | ENST00000510433.1 | n.174-14764C>T | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0187 AC: 2850AN: 152120Hom.: 64 Cov.: 34
GnomAD3 genomes
AF:
AC:
2850
AN:
152120
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0271 AC: 6727AN: 248304Hom.: 158 AF XY: 0.0299 AC XY: 4034AN XY: 134730
GnomAD3 exomes
AF:
AC:
6727
AN:
248304
Hom.:
AF XY:
AC XY:
4034
AN XY:
134730
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0228 AC: 33331AN: 1460694Hom.: 650 Cov.: 31 AF XY: 0.0246 AC XY: 17852AN XY: 726606
GnomAD4 exome
AF:
AC:
33331
AN:
1460694
Hom.:
Cov.:
31
AF XY:
AC XY:
17852
AN XY:
726606
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0188 AC: 2856AN: 152238Hom.: 64 Cov.: 34 AF XY: 0.0202 AC XY: 1502AN XY: 74444
GnomAD4 genome
AF:
AC:
2856
AN:
152238
Hom.:
Cov.:
34
AF XY:
AC XY:
1502
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
87
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at